ArticleDentistry journal2026

Chimeric Antigen Receptor T-Cell Therapy Is Associated with Low Absolute Rates of Orofacial Adverse Events and Significantly Less When Compared to Hemopoietic Stem Cell Therapy.

Stella O Oyewole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.